Stroke of Unknown Type Whether Ischemic or Hemorrhagic (ICD-11: 8B20)

Introduction

Stroke (cerebrovascular accident) represents one of the leading causes of mortality and permanent disability worldwide, affecting millions of people annually. This acute neurological condition occurs when the blood supply to a part of the brain is interrupted, resulting in damage to brain tissue. Traditionally, strokes are classified into two main subtypes: ischemic (caused by blockage of a blood vessel) and hemorrhagic (caused by vascular rupture and bleeding). However, there is an important clinical category that is frequently underestimated in medical practice: stroke of unspecified type, not known whether ischemic or hemorrhagic, coded as 8B20 in ICD-11.

This specific classification applies when a patient presents with unequivocal clinical manifestations of stroke, but the differentiation between ischemic and hemorrhagic subtypes has not been established through neuroimaging or other diagnostic methods. This situation is not uncommon in clinical practice, especially in contexts where immediate access to advanced imaging technologies is limited, in cases of early death before complementary examinations are performed, or when medical contraindications prevent the performance of neuroimaging.

The correct coding of this condition is critical for several reasons. First, it allows appropriate epidemiological recording of cases where complete characterization was not possible, maintaining the integrity of public health data. Second, it ensures appropriate documentation for reimbursement and hospital management purposes. Third, it facilitates communication among healthcare professionals about cases where diagnostic uncertainty remains. Finally, it contributes to healthcare quality studies, identifying gaps in access to essential diagnostic resources.

Correct ICD-11 Code

Code: 8B20

Description: Stroke, not known whether ischemic or hemorrhagic

Parent category: Cerebrovascular diseases

Official definition: This code applies when the patient meets clinical criteria for stroke, presenting with acute symptoms of focal cerebral injury that lasted 24 hours or longer (or that led to death before completing 24 hours), but the specific subtype of stroke (ischemic or hemorrhagic) was not determined by neuroimaging or other appropriate diagnostic techniques.

The classification 8B20 recognizes an important clinical reality: it is not always possible or feasible to determine with certainty the exact mechanism of the cerebrovascular event. This code should not be interpreted as a diagnostic failure, but rather as a legitimate category that reflects practical, logistical, or medical limitations that prevent complete characterization of the event.

It is fundamental to understand that this code belongs to the broad category of cerebrovascular diseases and maintains the same clinical and administrative importance as codes for specific stroke subtypes. The absence of subtype specification does not diminish the severity of the condition nor alter the need for emergency treatment and appropriate intensive care.

When to Use This Code

The code 8B20 should be used in specific clinical situations where the diagnostic criteria for stroke are present, but differentiation between subtypes remains indeterminate. Below are detailed practical scenarios:

Scenario 1: Early death before neuroimaging A 72-year-old patient is admitted to the emergency department with sudden hemiplegia and altered level of consciousness. The medical team identifies clear clinical signs of stroke and initiates preparation for computed tomography. However, the patient experiences rapid deterioration and dies 18 hours after symptom onset, before neuroimaging could be performed. In this case, code 8B20 is appropriate, as the clinical diagnosis of stroke is unequivocal, but the subtype remains unknown.

Scenario 2: Absolute contraindications for neuroimaging A patient with an incompatible cardiac pacemaker presents with acute focal neurological deficit with aphasia and unilateral weakness. Magnetic resonance imaging is contraindicated due to the implanted device, and computed tomography is not available at the health facility at the time of admission. The patient is transferred to another institution, but the initial record should use code 8B20 until neuroimaging is obtained.

Scenario 3: Unavailable diagnostic resources In a health facility with limited resources, a patient develops sudden focal neurological symptoms compatible with stroke. The computed tomography equipment is inoperative due to scheduled maintenance, and immediate transfer is not feasible due to adverse weather conditions. Treatment is initiated based on clinical evaluation, and code 8B20 appropriately documents the situation.

Scenario 4: Clinical instability preventing transport A critically ill patient presents with signs of stroke during hospitalization in an intensive care unit. Hemodynamic and respiratory instability makes transport to the imaging department extremely risky. The team decides that the risk of mobilization outweighs the benefits of immediate subtype characterization, maintaining supportive treatment. Code 8B20 reflects this clinical reality.

Scenario 5: Inadequate image quality Neuroimaging is performed, but technical artifacts, excessive patient movement, or other technical limitations result in images of insufficient quality to safely determine whether the stroke is ischemic or hemorrhagic. Repeating the examination is not immediately possible, and code 8B20 documents this diagnostic uncertainty.

Scenario 6: Documentation of historical cases When reviewing old medical records for epidemiological studies or audits, cases are identified where the clinical diagnosis of stroke was established, but the documentation does not specify the subtype and neuroimaging is not available in the files. Code 8B20 allows appropriate classification of these historical cases.

When NOT to Use This Code

It is equally important to understand the situations where code 8B20 should not be applied, avoiding coding errors that may compromise the quality of health data.

Exclusion 1: Sequelae of previous stroke When the patient presents with residual neurological deficits from a cerebrovascular accident that occurred in the past, even if the original subtype is unknown, the appropriate code is 557175275 (Sequela of cerebrovascular accident). Code 8B20 applies exclusively to the acute phase of the cerebrovascular event, not to its chronic consequences.

Exclusion 2: Stroke with determined subtype If neuroimaging or other diagnostic methods have clearly established that the stroke is ischemic or hemorrhagic, more specific codes should be used. 8B20 is reserved specifically for cases where this differentiation was not possible.

Exclusion 3: Transient ischemic attack (TIA) When focal neurological symptoms resolve completely in less than 24 hours and there is no evidence of permanent brain injury, it is a transient ischemic attack, not a stroke. Specific codes for TIA should be used in these circumstances.

Exclusion 4: Other causes of acute neurological deficit Conditions such as hemiplegic migraine, seizures with Todd's paralysis, severe hypoglycemia, or other metabolic causes can clinically mimic stroke. If appropriate investigation determines that the event was not vascular, code 8B20 does not apply.

Exclusion 5: Chronic cerebrovascular diseases without acute event Code 8B21 (Cerebrovascular disease without acute cerebral symptom) is appropriate for chronic or asymptomatic cerebrovascular conditions. 8B20 requires the presence of acute symptoms of focal brain injury.

Coding Step by Step

Step 1: Assess Diagnostic Criteria

The first crucial step is to confirm that the patient truly presents with a stroke based on established clinical criteria. This requires documentation of sudden onset of focal neurological deficit compatible with compromise of a specific cerebral vascular territory.

Symptoms should include manifestations such as hemiparesis or hemiplegia, language alterations (aphasia), visual deficits, altered level of consciousness, ataxia, or other focal neurological signs. The duration of symptoms is critical: they must persist for at least 24 hours or lead to death before this period.

Neurological evaluation should be documented using standardized scales when possible, such as the National Institutes of Health Stroke Scale (NIHSS) or similar scales. Complete physical examination should exclude non-vascular causes of symptoms.

Step 2: Verify Specifiers

After confirming the diagnosis of stroke, it is necessary to document additional characteristics that may be relevant. The severity of neurological deficit should be recorded, including the degree of functional impairment and level of consciousness.

The exact duration of symptoms from onset until medical evaluation should be established with the greatest possible precision, as this influences therapeutic decisions and prognosis. Information about preexisting vascular risk factors (arterial hypertension, diabetes, atrial fibrillation, smoking) should be collected.

The affected vascular territory should be identified clinically whenever possible, even in the absence of neuroimaging, based on the pattern of neurological deficits observed.

Step 3: Differentiate from Other Codes

Differentiation from Intracranial Hemorrhage: If neuroimaging or lumbar puncture clearly demonstrates the presence of blood in the cerebral parenchyma or subarachnoid spaces, specific codes for intracranial hemorrhage should be used. 8B20 is reserved for when this differentiation was not possible.

Differentiation from Cerebral Ischemia: When neuroimaging confirms an area of cerebral infarction without evidence of hemorrhage, or when other diagnostic methods establish with certainty the ischemic nature of the event, specific codes for cerebral ischemia are appropriate. 8B20 should not be used when the subtype has been determined.

Differentiation from 8B21 (Cerebrovascular Disease without Acute Symptom): The fundamental difference is the presence of acute symptoms. Code 8B21 applies to chronic cerebrovascular conditions, asymptomatic or in follow-up phase without current acute event. 8B20 requires acute symptomatology of focal cerebral injury.

Step 4: Necessary Documentation

Adequate documentation is essential to justify the use of code 8B20. The medical record should include:

Checklist of mandatory information:

Exact date and time of symptom onset
Detailed description of observed neurological deficits
Results of complete neurological examination
Scores on severity scales when applicable
Clear explanation of why neuroimaging was not performed or was inconclusive
Documentation of contraindications, unavailability of resources, or other reasons for absence of subtype characterization
Vital signs and relevant laboratory tests
Treatment instituted based on clinical evaluation
Patient's clinical course

This complete documentation not only justifies the coding but also legally protects the professionals involved and provides valuable information for continuity of care.

Complete Practical Example

Clinical Case

A 68-year-old male patient is brought to the emergency department by family members after being found on the floor of his residence at 2:30 PM. According to his wife's report, he was last seen at 1:45 PM without complaints, was well and walking normally. When found 45 minutes later, he presented with difficulty speaking and was unable to move the right side of his body.

Upon hospital admission at 3:10 PM, the patient is conscious but disoriented, with significant expressive aphasia, complete right hemiplegia and deviation of the oral commissure. Vital signs show blood pressure of 180/100 mmHg, heart rate of 92 bpm irregular, temperature of 36.8°C. Capillary blood glucose is 145 mg/dL, excluding hypoglycemia as a cause of symptoms.

Neurological examination reveals NIHSS of 18 points, indicating severe stroke. The patient has a history of uncontrolled arterial hypertension and atrial fibrillation diagnosed 3 years ago, but was not on anticoagulants. The medical team establishes a clinical diagnosis of acute cerebrovascular accident and initiates preparation for urgent cranial computed tomography.

While awaiting transport to the imaging department, the patient presents with sudden decrease in level of consciousness, progressing to coma (Glasgow Coma Scale 6). The team initiates resuscitation maneuvers, including orotracheal intubation and ventilatory support. Despite efforts, the patient presents with cardiopulmonary arrest at 5:20 PM and does not respond to resuscitation measures, being declared dead at 5:55 PM.

The total time from symptom onset to death was approximately 4 hours, insufficient to complete the neuroimaging investigation that was planned.

Step-by-Step Coding

Criteria Analysis:

Presence of acute symptoms of focal brain injury: Confirmed - the patient presented with sudden onset of aphasia and right hemiplegia, clearly compatible with compromise of left cerebral vascular territory.
Duration of symptoms: Although the patient died before 24 hours from symptom onset, the definition of code 8B20 specifically includes cases that "led to death before 24 hours," making this criterion satisfied.
Absence of subtype determination: The planned neuroimaging could not be performed due to rapid clinical deterioration and subsequent death. Therefore, it was not possible to determine whether the stroke was ischemic or hemorrhagic.

Code Selected: 8B20 - Stroke, not known whether ischemic or hemorrhagic

Complete Justification:

This case exemplifies perfectly the appropriate application of code 8B20. The clinical diagnosis of stroke is unequivocal, based on classic presentation with focal neurological deficits of sudden onset, neurological examination consistent with acute cerebrovascular event, and presence of significant vascular risk factors.

The inability to perform neuroimaging did not result from negligence or medical error, but rather from the rapid and fatal clinical evolution of the patient. The medical team acted appropriately, prioritizing stabilization and planning adequate investigation, but the severity of the event prevented its completion.

Applicable Complementary Codes:

Code for cardiopulmonary arrest (immediate cause of death)
Code for arterial hypertension (coexisting condition)
Code for atrial fibrillation (coexisting condition)

Documentation of this case with code 8B20 allows adequate epidemiological recording, acknowledges the clinical reality of the situation, and provides accurate information about the circumstances of the event for statistical and public health purposes.

Related Codes and Differentiation

Within the Same Category

Intracranial Hemorrhage vs. 8B20:

Intracranial hemorrhage is diagnosed when there is confirmed evidence of bleeding within the cranium, whether in the cerebral parenchyma, subarachnoid space, subdural or epidural space. The fundamental differentiation is diagnostic confirmation: intracranial hemorrhage requires unequivocal demonstration of blood through neuroimaging (computed tomography or magnetic resonance imaging) or lumbar puncture.

When to use intracranial hemorrhage: If computed tomography shows hyperdensity compatible with blood, or if magnetic resonance imaging demonstrates characteristic signals of hemorrhage, or if lumbar puncture reveals xanthochromia or red blood cells.

When to use 8B20: When the clinical presentation is compatible with stroke, but no diagnostic method was able to confirm or exclude hemorrhage.

Cerebral Ischemia vs. 8B20:

Cerebral ischemia is confirmed when neuroimaging or other methods establish that the event resulted from vascular blockade without associated hemorrhage. Computed tomography may show hypodensity in a specific vascular territory, or magnetic resonance imaging may demonstrate diffusion restriction characteristic of acute infarction.

When to use cerebral ischemia: If neuroimaging confirms an area of infarction without hemorrhagic component, or if vascular studies demonstrate arterial occlusion with consequent tissue ischemia.

When to use 8B20: When it was not possible to obtain imaging confirmation or when the examinations performed were inconclusive regarding the nature of the event.

8B21 (Cerebrovascular Disease Without Acute Symptom) vs. 8B20:

This differentiation is particularly important and frequently a source of confusion. Code 8B21 applies to cerebrovascular conditions that are not in the acute phase of a cerebrovascular event.

When to use 8B21: For chronic cerebrovascular disease, asymptomatic carotid stenosis, white matter changes on neuroimaging without corresponding acute event, or during outpatient follow-up of a patient with known cerebrovascular disease but without current acute symptoms.

When to use 8B20: Exclusively during an acute stroke event, with focal neurological symptoms of recent onset, when the subtype has not been determined.

Differential Diagnoses

Various conditions can mimic stroke clinically and should be considered in the differential diagnosis:

Hemiplegic migraine: Can cause transient focal neurological deficits, but there is usually a history of prior migraine and symptoms evolve more gradually.

Todd's paralysis: Focal post-ictal weakness after seizure can simulate stroke, but there is a history of convulsive activity preceding the deficit.

Severe hypoglycemia: Can cause focal deficits, but low blood glucose is easily identifiable and symptoms reverse with glucose correction.

Brain tumors: Can present with focal deficits, but usually with a more gradual course. Neuroimaging clearly differentiates.

Encephalitis: Can cause focal neurological symptoms, but usually accompanied by fever and more prominent alteration of consciousness.

Differences with ICD-10

In ICD-10, the closest equivalent code is I64 - Cerebrovascular accident, not specified as hemorrhagic or ischemic. Although conceptually similar, there are important differences in structure and application between the two classifications.

ICD-11 offers greater granularity and specificity in the definition of criteria, clearly stating that code 8B20 requires symptoms that lasted 24 hours or longer, or that led to death before this period. ICD-10 does not detail these temporal criteria with the same precision.

Another significant change is the clearer hierarchical structure in ICD-11, facilitating navigation between related codes and understanding of relationships between different categories of cerebrovascular diseases. ICD-11 also provides more explicit guidance on when to use this code versus more specific codes.

The practical impact of these changes includes greater precision in coding, better international comparability of epidemiological data, and reduction of ambiguities that frequently occurred with ICD-10. For coding professionals and clinical documentation specialists, the transition requires familiarity with the new more specific criteria, but results in more accurate classification of cases.

Frequently Asked Questions

1. How is stroke diagnosis made when neuroimaging is not available?

Stroke diagnosis is based primarily on clinical criteria: sudden onset of focal neurological deficit compatible with a specific cerebral vascular territory. The evaluation includes detailed clinical history, complete neurological examination using standardized scales, and exclusion of non-vascular causes through basic laboratory tests. Although neuroimaging is ideal for confirming the diagnosis and determining the subtype, its absence does not prevent clinical recognition of stroke. Experienced professionals can diagnose stroke with high accuracy based on clinical presentation, especially when known vascular risk factors are present and the pattern of deficits is characteristic.

2. Is treatment available in public health systems?

Treatment for acute stroke varies considerably among different health systems, but generally includes vital support measures, blood pressure control, management of complications, and rehabilitation. Public health systems in many countries offer basic stroke treatment, although access to advanced therapies such as thrombolysis or mechanical thrombectomy may be limited in some regions. The availability of specialized stroke units also varies. Regardless of whether the subtype is known, general support measures and prevention of complications are fundamental and should be available in any service that provides neurological emergency care.

3. How long does treatment last?

Stroke treatment occurs in distinct phases. The acute phase, in the first hours and days, focuses on stabilization, prevention of complications, and, when the subtype is known, specific therapies. This phase generally requires hospitalization for days to weeks, depending on severity. The subacute phase involves intensive rehabilitation, which may last weeks to months. The chronic phase includes secondary prevention and management of sequelae, which continues indefinitely. Even when the initial subtype was not determined (code 8B20), the patient may eventually have later characterization or follow-up based on clinical manifestations and risk factors.

4. Can this code be used in medical certificates?

Yes, code 8B20 can and should be used in official medical documentation, including certificates, when appropriate. The certificate should describe "stroke" as the diagnosis, and may specify that the subtype was not determined if relevant to the context. For purposes of work leave or other administrative needs, the diagnosis of stroke is sufficient regardless of subtype characterization. The severity of sequelae and functional limitations, not the specific subtype, generally determines recommendations regarding work capacity and need for leave.

5. Is it possible to determine the subtype later?

Yes, it is often possible to characterize the stroke subtype at a time later than the acute event. Neuroimaging performed days or weeks after the initial event may reveal characteristics that allow retrospective classification. Magnetic resonance imaging is particularly useful for identifying old infarcts or evidence of previous hemorrhage. When this occurs, coding should be updated to reflect the determined subtype, and code 8B20 is no longer appropriate. However, in cases where the patient died early or never underwent adequate neuroimaging, code 8B20 remains as the definitive record.

6. What are the main reasons for not performing neuroimaging?

The most common causes include: early death before the examination is performed, severe clinical instability that makes transport too risky, absolute contraindications (such as pacemakers incompatible with magnetic resonance imaging), equipment unavailability due to technical or logistical issues, resource limitations in units with limited infrastructure, and patient or family refusal. In some situations, multiple factors contribute simultaneously. It is important to clearly document the specific reason in each case.

7. Does prognosis differ when the subtype is unknown?

Stroke prognosis depends fundamentally on the extent of brain injury, affected vascular territory, severity of initial deficits, presence of complications, and access to adequate rehabilitation. Although the subtype influences prognosis (hemorrhagic strokes tend to have higher acute mortality, while ischemic ones have higher recurrence risk), the absence of subtype characterization does not alter the prognosis itself, only limits the precision of risk stratification. Management focused on prevention of complications and adequate rehabilitation remains fundamental regardless of whether the subtype is known.

8. How to proceed with secondary prevention when the subtype is unknown?

Secondary prevention when the subtype has not been determined is based on general principles of vascular risk reduction: strict blood pressure control, diabetes management, smoking cessation, dyslipidemia control, and lifestyle modifications. Regarding antiplatelet or anticoagulation therapy, the decision should consider individual risk factors. Patients with atrial fibrillation generally benefit from anticoagulation regardless of subtype. In the absence of clear indication for anticoagulation, platelet antiaggregation is generally appropriate. When possible, efforts should be made to characterize the subtype later, allowing for a more targeted prevention strategy.

Conclusion

The ICD-11 code 8B20 - Stroke, not known whether ischemic or hemorrhagic - represents an important diagnostic category that acknowledges the practical limitations of real-world medicine. Its appropriate use requires clear understanding of diagnostic criteria, the clinical situations where it applies, and the necessary differentiation from other related codes. Adequate documentation and correct use of this code contribute to the quality of public health data, allow for accurate epidemiological recording, and facilitate communication among health professionals. Although characterization of stroke subtype is ideal whenever possible, category 8B20 ensures that cases where this determination was not feasible are still adequately classified and recorded in the health system.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Stroke of unknown type, whether ischemic or hemorrhagic

Compartir